Cultured cells of different chemicallyinduced C57BL/6N murine sarcomas produced variable amounts of infectious murine leukemia virus (MuLV) and contained proportional amounts of MuLV structural components as determined by radioimmunoassay. Monospecific antisera directed against the major MuLV glycoprotein (gp7l), the major internal antigen (p30), and the ribonucleoprotein (plO) were capable of mediating tumor cell lysis in the presence of complement, suggesting that these viral structural components were localized at least in part to the cell surface. Membrane immunofluorescence studies with MuLV p30 antiserum confirmed surface localization. Addition of MuLV p30 polypeptide to normal cells and tumor cells enhanced the cytotoxicity of MuLV p30 antiserum. Studies are presented which suggest that the presence of MuLV structural components on cell surfaces can be independent of virus production and cellular transformation.
Genetic material of murine leukemia virus (MuLV) is contained in the DNA The biological significance of endogenous MuLV genetic information is under study. Our effort has been concerned with changes in cell surface membranes. In addition to virusinduced neoantigens (3) , and possibly expression of fetal antigens (4) , it has been reported that a major internal MuLV polypeptide (designated 1)30) is also expressed on the surface of cells that replicate activated MuLV (5) . The mechanism whereby this polypeptide appears on the cell surface and its significance are not clear.
Recent work in this and other laboratories suggests that antigenic similarities exist between different chemicallyinduced syngeneic murine tumors (6) (7) (8) . Such similarities might be due to common tumor associated surface antigens, reexpression of fetal antigens, or common antigens arising from activation of endogenous viruses. Since chemical carcinogens can activate M\uLV, it was important to determine if our chemically induced tumors expressed MuLV structural antigens on their surface membranes and if these antigens participated in the host's immunological response to the tumors.
Abbreviations: AMIV, avian myeloblastosis virus; FeLV, feline leukemia virus-Rickard strain; FI, fluorescent index; FIU, focus inducing unit; MCA, 3-methylcholanthrene; MuLV, murine leukemia virus-Friend strain; NEF, normal embryonic fibroblasts.
MATERIALS AND METHODS
Cultured Cell Lines. Six C57BL/6N murine sarcomas (designated MCA-4,5,6,10, 11, and 18) induced by 3-methylcholanthrene (MCA) and normal 18-day-old C57BL/6N embryonic fibroblasts (NEF) were explanted into cell culture.
S+L-m3 transformed cells (9, 10) and the nontransformed spontaneous revertant designated m3SR (11) Radioimmunoassay of MhuLV Polypeptides. Radioimmunoassays were performed as previously described (19, 20) . The 50% endpoint serum titer for competition was determined by direct double antibody radioimmunoassay (19 (Fig. 2) . Patterns of fluorescent-staining included concentric ring fluorescence, partial ring staining, and patch formation (Fig. 3) . Yoshiki (Table 3 ). This is consistent with the relative proportions of intraspecies and interspecies antigenic determinants of MuLV p30 (24) . These findings suggested that both determinants of MuLV p30 were expressed by MCA-6 and MCA-10 cells and indicated that each determinant was accessible to antibody. The same conclusion was reached by Expression of MuLV genetic information by these cell lines is given in Table 4 . Cytotoxicity was unrelated to cellular transformation or virus particle production.
ways ( Table 4 ). As shown in Fig. 4 , low dilutions of MuLV p30 antiserum were toxic to the two nontransformed lines (m3SR and BALB/3T3) and to one transformed line (S+L-m3) but not to the transformed K234 line.
Our previous findings of p30 antiserum toxicity against nonvirus-producing MCA-induced tumor lines (MCA-4 and MCA-11) as well as virus-producing lines (MCA-5, MCA-6, and MCA-10) suggested that p30 expression was not dependent upon virus synthesis. These findings were supported by p30 antiserum toxicity against m3SR and BALB/3T3 cell lines which produced no detectable MuLV. It appears, therefore, that cell surface expression of p30 is poorly related to either cellular transformation or virus synthesis but correlated best to cellular p30 content. This correlation, however, was not quantitative as p30 content by radioimmunoassay did not always agree with observed cytotoxicity of p30 antiserum (Tables 1 and 4 , Figs. 1 and 4) . Further, MuLV p30 antiserum in our assay showed no cytotoxicity to nonvirus-producing, transformed human cells known to contain the murine sarcoma genome (Hu S+L-) (25) and significant amounts of p30 by radioimmunoassay (80 ng/106 cells).
To determine if MuLV p30 antigen passively associated with cell surfaces, NEF cells, which contained minimal quantities of MuLV p30 and were not lysed by MuLV p30 antiserum, were incubated for 2 hr with MuLV P30 polypeptide, washed, and studied for sensitivity to MuLV p30 antiserum in cytotoxicity assays. Significant enhancement occurred when 0.1-0.8 ,ug of p30 were added per 103 cells (Fig. 5) . This cytotoxicity was abolished by absorption of the antiserum with MuLV p30 polypeptide. Preincubation with larger amounts of MuLV p30 was less effective perhaps due to excess p30 which could compete with cell bound p30 for antibody. Similar enhancement of cytotoxicity by addition of p30 was observed with MCA-18 and MCA-4 tumor cells.
From these experiments, passive absorption of extracellular MuLV p30 onto the cell surface became an important consideration. Although no solubilized MuLV p30 in MCA-10 cell culture supernatants could be detected by radioimmunoassay, this did not rule out the possibility that p30 derived from disrupted virus or from cells rapidly attached to the cell surface. Yet, the cytotoxicity of MuLV p30 antiserum against m3SR and BALB/3T3, two nonvirus-producing cell lines (Fig.   4 (28) . In fact, chf has been shown to be analogous to the avian virus glycoprotein, gp85 (29) .
The presence of internal structural virus constituents on the cell surface, such as the major core protein (p30) and possibly the polypeptide closely associated with virus RNA (plO), was unexpected. This may be unique for mammalian oncornavirus systems since attempts to detect the corresponding avian constituents have been unsuccessful (30) . The mechanism by which these polypeptides arrive at the cell surface is unclear. Although we were able to generate cytotoxicity by addition of purified MuLV p30 to cells, the finding that MuLV p30 antiserum was cytotoxic against nonvirus-producing cell lines suggests that the antigen does not originate exclusively as a consequence of virus production and subsequent disruption. Yet, the possibility remains that MuLV p30 arrives at the cell surface as a result of disruption of other cells. More work needs to be done to relate these observations to the morphogenesis of MuLV.
The demonstration that both interspecies and intraspecies determinants of the surface glycoprotein (gp7l) and internal polypeptide (p30) were present on the surface of MCAinduced murine tumor cells, bound antibody, and mediated cell lysis has broad implications. Clearly, such reactivities must be accounted for in studies dealing with tumor antigens or tissue antigens within the mouse species or between different species. Indeed, preliminary studies in our laboratory have shown that cells of a MCA-induced rat sarcoma were lysed by goat antiserum to FeLV.
Although in vitro we were unable to detect MuLV p30 antibody in murine antiserum directed against a syngeneic MCAinduced tumor which expressed surface-bound MuLV p30, this does not rule out the possibility of in vivo interactions. Other structural antigens or virus-induced neoantigens (3) need to be studied in a similar manner. This is particularly important with regard to gp7l and p15 since certain mouse strains contain antibodies against these components (refs. 31 and 32; R. Lerner and T. August, personal communications). The relationship of these components to one another in vito may have even broader implications and also needs to be examined. The 
